Low levels of follicle-stimulating hormone receptor-activation inhibitors in serum and follicular fluid from normal controls and anovulatory patients with or without polycystic ovary syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 5, 1997, Pages 1325-1331

  Schipper, Izaäk ^a   Rommerts, Focko F G ^a   Ten Hacken, Paulien M ^a   Fauser, Bart C J M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; ANDROSTENEDIONE; COMPLEMENTARY DNA; CYCLIC AMP; ESTRADIOL; FOLLITROPIN; FOLLITROPIN RECEPTOR;

ADULT; ANIMAL CELL; ANOVULATION; ARTICLE; CELL SECRETION; CHO CELL; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DNA TRANSFECTION; FEMALE; HORMONAL REGULATION; HUMAN; MENSTRUAL CYCLE; NONHUMAN; OVARY FOLLICLE DEVELOPMENT; OVARY FOLLICLE FLUID; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

EID: 0030918076     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.5.1325     Document Type: Article

References (44)

1. Fauser BCJM, Pache TD, Lamberts SW, Hop WC, de Jong FH, Dahl KD. 1991 Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease. J Clin Endocrinol Metab. 73:811-817.
2. Franks S. 1995 Polycystic ovary syndrome. N Engl J Med. 333:853-861.
3. Pache TD, Hop WC, de Jong FH, et al. 1992 17 β-Oestradiol, androstenedione and inhibin levels in fluid from individual follicles of normal and polycystic ovaries, and in ovaries from androgen treated female to male transsexuals. Clin Endocrinol (Oxf). 36:565-571.
4. Fauser BCJM. 1994 Observations in favor of normal early follicular development and disturbed dominant follicle selection in polycystic ovary syndrome. Gynecol Endocrinol. 8:75-82.
5. Van Dessel HJHM, School BC, Schipper I, Dahl KD, Fauser BCJM. 1996 Circulating immunoactive and bioactive follicle stimulating hormone concentrations in anovulatory infertile women and during gonadotrophin induction of ovulation using a decremental dose regimen. Hum Reprod. 11:478-485.
6. Schoot DC, Hop WC, Pache TD, de Jong FH, Fauser BCJM. 1993 Growth of the dominant follicle is similar to normal in patients with gonadotropin-stimulated polycystic ovary syndrome exhibiting monofollicular development during a decremental dose regimen. Acta Endocrinol (Copenh) 129:126-129.
7. Erickson GF, Hsueh AJW, Quigley ME, Rebar RW, Yen SSC. 1979 Functional studies of aromatase activity in human granulosa cells from normal and polycystic ovaries. J Clin Endocrinol Metab. 49:514-519.
8. Mason HD, Willis DS, Beard RW, Winston RML, Margara R, Franks S. 1994 Estradiol production by granulosa cells of normal and polycystic ovaries (PCO): relationship to menstrual cycle history and to concentrations of gonadotropins and sex steroids in follicular fluid. J Clin Endocrinol Metab. 79:1355-1360.
9. Hsueh AJW, Adashi EY, Jones PBC, Welsh J, T.H. 1984 Hormonal regulation of the differentiation of cultured ovarian granulosa cells. Endocr Rev. 5:76-127.
10. Tonetta SA, DiZerega GS. 1989 Intragonadal regulation of follicular maturation. Endocr Rev. 10:205-229.
11. Greenwald GS, Roy SK. 1994 Follicular development and its control. In: Knobil E, Neill JD, eds. The physiology of reproduction. 2nd ed. New York: Raven Press; 629-724.
12. Fauser BCJM. 1996 Interference with follicle stimulating hormone regulation of human ovarian function. Mol Hum Reprod. 2:327-334.
13. Giudice LC. 1992 Insulin-like growth factors and ovarian follicular development. Endocr Rev. 13:641-669.
14. Miro F, Hillier SG. 1992 Relative effects of activin and inhibin on steroid hormone synthesis in primate granulosa cells. J Clin Endocrinol Metab. 75:1556-1561.
15. Van Santbrink EJP, Hop WC, Van Dessel HJHM, de Jong FH, Fauser BCJM. 1995 Decremental follicle-stimulating hormone and dominant follicle development during the normal menstrual cycle. Fertil Steril. 64:37-43.
16. Steinkampf MP, Mendelson CR, Simpson ER. 1988 Effects of epidermal growth factor and insulin-like growth factor I on the levels of mRNA encoding aromatase cytochrome P-450 of human ovarian granulosa cells. Mol Cell Endocrinol. 59:93-99.
17. Mason HD, Margara R, Winston RML, Beard RW, Reed MJ, Franks S. 1990 Inhibition of oestradiol production by epidermal growth factor in human granulosa cells of normal and polycystic ovaries. Clin Endocrinol (Oxf). 33:511-517.
18. Reichert Jr LE, Sanzo MA, Darga NS. 1979 Studies on a low molecular weight follicle-stimulating hormone binding inhibitor from human serum. J Clin Endocrinol Metab. 49:866-872.
19. Sanzo MA, Reichert Jr LE. 1982 Gonadotropin receptor binding regulators in serum: characterization and separation of follitropin binding inhibitor and lutropin binding stimulator. J Biol Chem. 257:6033-6040.
20. Fletcher PW, Dias JA, Sanzo A, Reichert Jr LE. 1982 Inhibition of FSH action on granulosa cells by low molecular weight components of follicular fluid. Mol Cell Endocrinol. 25:303-315.
21. 125I-human follicle-stimulating hormone binding to receptor by low molecular weight fraction of bovine follicular fluid: inhibitor concentration is related to biochemical parameters of follicular development. Biol Reprod. 29:1105-1113.
22. Lee DW, Butler WJ, Horvath PM, Shelden RM, Reichert Jr LE. 1991 Human follicular fluid contains a follicle-stimulating hormone (FSH) binding inhibitor which has FSH agonist activity, is immunologically similar to FSH, but can be distinguished from FSH. J Clin Endocrinol Metab. 72:1102-1107.
23. Lee DW, Grasso P, Dattatreyamurty B, Deziel MR, Reichert Jr LE. 1993 Purification of a high molecular weight follicle-stimulating hormone receptor-binding inhibitor from human follicular fluid. J Clin Endocrinol Metab. 77:163-168.
24. van Weissenbruch MM, Hoek A, van Vliet Bleeker I, Schoemaker J, Drexhage H. 1991 Evidence for existence of immunoglobulins that block ovarian granulosa cell growth in vitro. A putative role in resistant ovary syndrome? J Clin Endocrinol Metab. 73:360-367.
25. Schipper I, Fauser BCJM, Ten Hacken PM, Rommerts FFG. 1996 Application of a CHO cell line, transfected with the human FSH receptor for the measurement of specific FSH receptor activation inhibitors in human serum. J Endocrinol. 150:505-514.
26. Pache TD, Hop WCJ, Wladimiroff JW, Schipper J, Fauser BCJM. 1992 How to discriminate between normal and polycystic ovaries. A transvaginal ultrasound study. Radiology. 183:421-423.
27. Van Dessel HJHM, Schipper I, Pache TD, van Geldorp H, de Jong FH, Fauser BCJM. 1996 Normal human follicle development: and evaluation of correlations with oestradiol, androstenedione and progesterone levels in individual follicles. Clin Endocrinol (Oxf) 44:191-198.
28. McNatty KP, Moore Smith D, Makris A, Osathanondh R, Ryan KJ. 1979 The microenvironment of the human antral follicle: interrelationships among steroid levels in antral fluid, the population of granulosa cells, and the status of the oocyte in vivo and in vitro. J Clin Endocrinol Metab. 49:851-860.
29. Erickson GF, Magoffin DA, Garzo VG, Cheung AF, Chang RJ. 1992 Granulosa cells of polycystic ovaries: are they normal or abnormal? Hum Reprod. 7:293-299.
30. McNatty KP. 1979 Cyclic changes in antral fluid hormone concentrations in humans. J Clin Endocrinol Metab. 7:577-600.
31. Downs TR, Wilfinger WW. 1983 Fluorometric quantification of DMA in cells and tissue. Anal Biochem. 131:538-547.
32. Harper JF, Brooket G. 1975 Femtomole sensitive radioimmunoassay for cyclic AMP and cycli GMP after 2′0′-acetylation by acetic anhydride in aqueous solution. J Cycl Nucl Res. 1:207-218.
33. Frohlich M, Brand EC, van Hall EV. 1976 Serum levels of unconjugated aeticholanolone, androstenedione, testosterone, dehydroepiandrosterone, aldosterone, progesterone, and oestrogens during the normal menstrual cycle. Acta Endocrinol (Copenh) 81:548-562.
34. Christin-Maitre S, Taylor AE, Khoury RH, et al. 1996 Homologous in vitro bioassay for follicle-stimulating hormone (FSH) reveals increased FSH biological signal during the mid- to late luteal phase of the human menstrual cycle. J Clin Endocrinol Metab. 81:2080-2088.
35. Jia X, Hsueh AJW. 1986 Granulosa cell aromatase bioassay for follicle-stimulating hormone: validation and application of the method. Endocrinology. 119:1570-1577.
36. Padmanabhan V, Chappel SC, Beitins IZ. 1987 An improved in vitro bioassay for follicle-stimulating hormone (FSH): suitable for measurement of FSH in unextracted human serum. Endocrinology. 121:1089-1098.
37. Lee DW, Shelden RM, Reichert Jr LE. 1990 Identification of low and high molecular weight follicle-stimulating hormone receptor-binding inhibitors in human follicular fluid. Fertil Steril. 53:830-835.
38. Leung PCK, Steele GL. 1992 Intracellular signalling in the gonads. Endocr Rev. 13:476-498.
39. Sharma OP, Flores JA, Leong DA, Veldhuis JD. 1994 Cellular basis for follicle-stimulating hormone-stimulated calcium signalling in single rat Sertoli cells: possible dissociation from effects of adenosine 3′,5′-monophosphate. Endocrinology. 134:1915-1923.
40. Gorczynska E, Spaliviero J, Handelsman DJ. 1994 The relationship between 3′,5′-cyclic adenosine monophosphate and calcium in mediating follicle-stimulating hormone signal transduction in Sertoli cells. Endocrinology. 134:293-300.
41. Anasti JN, Flack MR, Froehlich J, Nelson LM. 1995 The use of human recombinant gonndotropin receptors to search for immunoglobulin G-mediated premature ovarian failure. J Clin Endocrinol Metab. 80:824-828.
42. Fauser BCJM, van Heusden AM. 1997 Manipulation of human ovarian function; physiological concepts and clinical consequences. Endocr Rev. 18:71-106.
43. Van Santbrink EJP, Donderwinkel PFJ, Van Dessel HJHM, Fauser BCJM. 1995 Gonadotrophin induction of ovulation using a step-down dose regimen: single-centre clinical experience in 82 patients. Hum Reprod. 10:1048-1053.
44. Van Dessel HJHM, Chandrasekher Y, Yap OWS, et al. 1996 Serum and follicular fluid levels of insulin-like growth factor I (IGF-I), IGF-II, and IGF-Binding protein-1 and -3 during the normal menstrual cycle. J Clin Endocrinol Metab. 81:1224-1231.